Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. News
  7. Summary
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Syngene International Limited Announces Resignation of John M M Shaw from the Board of Directors

07/20/2021 | 10:10pm EDT

Syngene International Limited announced that Mr. John M M Shaw (DIN: 00347250) (Non-Executive, Non-Independent Director), vide his letter dated July 20, 2021 has communicated his intention to step down from the Board of Directors of the Company due to health reasons with effect from conclusion of the Annual General Meeting of the Company scheduled on July 21, 2021.


ę S&P Capital IQ 2021
All news about SYNGENE INTERNATIONAL LIMITED
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the Board of ..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Director (Indep..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in India
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene International Limited
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surge..
RE
04/28SYNGENE INTERNATIONAL : Posts Higher Profit in January-March
MT
04/27Syngene International Limited Reports Earnings Results for the Fourth Quarter Ended Mar..
CI
More news
Financials
Sales 2022 25 504 M 346 M 346 M
Net income 2022 4 408 M 59,7 M 59,7 M
Net cash 2022 4 104 M 55,6 M 55,6 M
P/E ratio 2022 58,9x
Yield 2022 0,07%
Capitalization 256 B 3 465 M 3 465 M
EV / Sales 2022 9,87x
EV / Sales 2023 8,24x
Nbr of Employees 5 437
Free-Float 28,7%
Chart SYNGENE INTERNATIONAL LIMITED
Duration : Period :
Syngene International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNGENE INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 644,90 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan Hunt Chief Executive Officer, MD & Executive Director
Sibaji Biswas Chief Financial Officer
Kiran Mazumdar-Shaw Non-Executive Chairman
Mahesh K Bhalgat Chief Operating Officer
Priyadarshini I. Mahapatra Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNGENE INTERNATIONAL LIMITED0.83%3 465
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353